Metacrine, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 62.21 million compared to USD 37.3 million a year ago. Basic loss per share from continuing operations was USD 2.29 compared to USD 3.97 a year ago.
1st Jan change | Capi. | |
---|---|---|
+25.69% | 48.09B | |
+46.90% | 40.62B | |
-3.46% | 40.43B | |
-6.20% | 28.36B | |
+9.17% | 24.89B | |
-20.42% | 19.01B | |
+28.07% | 12.09B | |
+0.17% | 11.88B | |
-1.24% | 11.8B |